Insider Selling: Terrence Mulligan Sells 1,000 Shares of MedAssets Stock (MDAS)
MedAssets (NASDAQ:MDAS) Director Terrence Mulligan sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, October 8th. The shares were sold at an average price of $24.64, for a total transaction of $24,640.00. Following the completion of the transaction, the director now directly owns 776 shares of the company’s stock, valued at approximately $19,121. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
MDAS has been the subject of a number of recent research reports. Analysts at Raymond James downgraded shares of MedAssets from a “strong-buy” rating to a “market perform” rating in a research note to investors on Tuesday, October 1st. Separately, analysts at Sterne Agee reiterated a “top pick” rating on shares of MedAssets in a research note to investors on Monday, September 16th. They now have a $30.00 price target on the stock, up previously from $25.00. Finally, analysts at Lazard Capital Markets downgraded shares of MedAssets from a “buy” rating to a “neutral” rating in a research note to investors on Monday, September 16th. They now have a $25.00 price target on the stock. They noted that the move was a valuation call. Five research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $26.19.
MedAssets (NASDAQ:MDAS) traded down 0.53% during mid-day trading on Tuesday, hitting $24.57. The stock had a trading volume of 473,373 shares. MedAssets has a 52-week low of $15.40 and a 52-week high of $25.72. The stock’s 50-day moving average is $24.00 and its 200-day moving average is $20.30. The company has a market cap of $1.504 billion and a price-to-earnings ratio of 368.66.
MedAssets (NASDAQ:MDAS) last announced its earnings results on Wednesday, July 31st. The company reported $0.30 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.26 by $0.04. The company had revenue of $170.70 million for the quarter, compared to the consensus estimate of $167.64 million. During the same quarter last year, the company posted $0.28 earnings per share. MedAssets’s revenue was up 4.7% compared to the same quarter last year. On average, analysts predict that MedAssets will post $1.31 earnings per share for the current fiscal year.
MedAssets, Inc (NASDAQ:MDAS) provides technology-enabled products and services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.